N-Terminal Extensions Retard Aβ42 Fibril Formation but Allow Cross-Seeding and Coaggregation with Aβ42

作者: Olga Szczepankiewicz , Björn Linse , Georg Meisl , Eva Thulin , Birgitta Frohm

DOI: 10.1021/JACS.5B07849

关键词: NucleationCircular dichroismPeptide sequenceChemistryMonomerCleavage (embryo)BiophysicsFibrilThioflavinKineticsCrystallography

摘要: Amyloid β-protein (Aβ) sequence length variants with varying aggregation propensity coexist in vivo, where coaggregation and cross-catalysis phenomena may affect the process. Until recently, naturally occurring amyloid were believed to begin at or after canonical β-secretase cleavage site within precursor. However, N-terminally extended forms of Aβ (NTE-Aβ) recently discovered contribute Alzheimer's disease. Here, we have used thioflavin T fluorescence study kinetics Aβ42 N-terminal extensions 5-40 residues, transmission electron microscopy analyze end states. We find that all form fibrils similar morphology as Aβ42, but half-time (t1/2) increases exponentially extension length. Monte Carlo simulations model peptides suggest retardation is due an underlying general physicochemical effect involving reduced frequency productive molecular encounters. Indeed, global kinetic analyses reveal NTE-Aβ42s via same mechanism microscopic rate constants (primary secondary nucleation, elongation) are for variants. Still, NTE-Aβ42 coaggregate mixed either catalyze monomers. monomers display kinds seeds implying termini interfere ability nucleate elongate. Cross-seeding therefore represent important contribution vivo formation assemblies be

参考文章(61)
Ivano Bertini, Leonardo Gonnelli, Claudio Luchinat, Jiafei Mao, Antonella Nesi, A new structural model of Aβ40 fibrils. Journal of the American Chemical Society. ,vol. 133, pp. 16013- 16022 ,(2011) , 10.1021/JA2035859
E. Gowing, A.E. Roher, A.S. Woods, R.J. Cotter, M. Chaney, S.P. Little, M.J. Ball, Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. Journal of Biological Chemistry. ,vol. 269, pp. 10987- 10990 ,(1994) , 10.1016/S0021-9258(19)78080-6
Dennis J. Selkoe, The therapeutics of Alzheimer's disease: Where we stand and where we are heading Annals of Neurology. ,vol. 74, pp. 328- 336 ,(2013) , 10.1002/ANA.24001
John Hardy, The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal Journal of Neurochemistry. ,vol. 110, pp. 1129- 1134 ,(2009) , 10.1111/J.1471-4159.2009.06181.X
Erik Portelius, Maria Olsson, Gunnar Brinkmalm, Ulla Rüetschi, Niklas Mattsson, Ulf Andreasson, Johan Gobom, Ann Brinkmalm, Mikko Hölttä, Kaj Blennow, Henrik Zetterberg, Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's disease. Journal of Alzheimer's Disease. ,vol. 33, pp. 85- 93 ,(2012) , 10.3233/JAD-2012-120994
Dominic M. Walsh, Eva Thulin, Aedín M. Minogue, Niklas Gustavsson, Eric Pang, David B. Teplow, Sara Linse, A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide. FEBS Journal. ,vol. 276, pp. 1266- 1281 ,(2009) , 10.1111/J.1742-4658.2008.06862.X
Michael T. Colvin, Robert Silvers, Birgitta Frohm, Yongchao Su, Sara Linse, Robert G. Griffin, High resolution structural characterization of Aβ42 amyloid fibrils by magic angle spinning NMR. Journal of the American Chemical Society. ,vol. 137, pp. 7509- 7518 ,(2015) , 10.1021/JACS.5B03997
Yiling Xiao, Buyong Ma, Dan McElheny, Sudhakar Parthasarathy, Fei Long, Minako Hoshi, Ruth Nussinov, Yoshitaka Ishii, Aβ(1–42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's disease Nature Structural & Molecular Biology. ,vol. 22, pp. 499- 505 ,(2015) , 10.1038/NSMB.2991
Sara Linse, Björn Linse, Protein folding through kinetic discrimination Journal of the American Chemical Society. ,vol. 129, pp. 8481- 8486 ,(2007) , 10.1021/JA070386E